---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-032857"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2022-11-18T23:59:59+00:00"
generated_at: "2026-06-21T15:52:26.398118+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Biotricity Q2 FY2023 revenue $2.4M, up 14% sequentially; net loss $4.9M

## Summary
- Revenue $2.4M, up 14% QoQ; gross profit $1.3M (54% margin).
- Net loss $4.9M ($0.094 per share) for quarter ended Sept 30, 2022.
- Bioheart monitor won TIME's Best Inventions 2022; awarded $250K NIH grant.
- Surpassed 2 billion recorded heartbeats for AFib; launched Biocare Cardiac Disease Management Solution.
- Maintained 95%+ customer retention; new distribution partnerships signed.

## SEC filing metadata
- accession: 0001493152-22-032857
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2022-11-18T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315222032857/0001493152-22-032857-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315222032857/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-032857
- JSON: https://secwatch.observer/filing/0001493152-22-032857.json
- Plain text: https://secwatch.observer/filing/0001493152-22-032857.txt

## Key facts
- Earnings Releases
  BIOTRICITY INC. reported fiscal 2023 second quarter ended September 30, 2022 results: revenue $2.4 million, net income $4.9 million, EPS $0.094 per share.
  - Period: fiscal 2023 second quarter ended September 30, 2022
  - Revenue: $2.4 million
  - Net income: $4.9 million
  - EPS: $0.094 per share
  - Result: reported results
  source text: Q2-FY23 Financial Highlights: ● Revenue totaled $2.4 million. ● Gross profit totaled $1.3 million. ● Gross profit margins were 54%. ● Net loss totaled $4.9 million or $0.094 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315222032857/0001493152-22-032857-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.